about
Targeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromesRole of mecp2 in experience-dependent epigenetic programmingMeCP2 Affects Skeletal Muscle Growth and Morphology through Non Cell-Autonomous MechanismsRett Syndrome: Reaching for Clinical TrialsMechanisms of Functional Hypoconnectivity in the Medial Prefrontal Cortex of Mecp2 Null Mice.Therapeutic Potential of Transcranial Focused Ultrasound for Rett Syndrome.Targeted delivery of brain-derived neurotrophic factor for the treatment of blindness and deafness.A BDNF loop-domain mimetic acutely reverses spontaneous apneas and respiratory abnormalities during behavioral arousal in a mouse model of Rett syndrome.Functional and structural specific roles of activity-driven BDNF within circuits formed by single spiny stellate neurons of the barrel cortex.Excitation/inhibition imbalance and impaired synaptic inhibition in hippocampal area CA3 of Mecp2 knockout miceTranscriptome comparison of human neurons generated using induced pluripotent stem cells derived from dental pulp and skin fibroblastsBrain-derived neurotrophic factor inhibits calcium channel activation, exocytosis, and endocytosis at a central nerve terminal.Screening for Small-Molecule Modulators of Long Noncoding RNA-Protein Interactions Using AlphaScreen.MicroRNAs downregulated in neuropathic pain regulate MeCP2 and BDNF related to pain sensitivity.MeCP2 SUMOylation rescues Mecp2-mutant-induced behavioural deficits in a mouse model of Rett syndrome.Reduced neuronal size and mTOR pathway activity in the Mecp2 A140V Rett syndrome mouse modelNeurobiologically-based treatments in Rett syndrome: opportunities and challenges.Primetime for Learning Genes.Analysis of the Serotonergic System in a Mouse Model of Rett Syndrome Reveals Unusual Upregulation of Serotonin Receptor 5bTranscriptional and epigenetic regulation of Hebbian and non-Hebbian plasticity.MeCP2: multifaceted roles in gene regulation and neural development.Unusual characteristics of the DNA binding domain of epigenetic regulatory protein MeCP2 determine its binding specificity.The Role of Noncoding RNAs in Neurodevelopmental Disorders: The Case of Rett Syndrome.Epigenetic mechanisms in neurogenesis.Inhibition of miR-15a Promotes BDNF Expression and Rescues Dendritic Maturation Deficits in MeCP2-Deficient Neurons.The BDNF val-66-met Polymorphism Affects Neuronal Morphology and Synaptic Transmission in Cultured Hippocampal Neurons from Rett Syndrome Mice.D-cycloserine improves synaptic transmission in an animal mode of Rett syndrome.Differential Expression and Regulation of Brain-Derived Neurotrophic Factor (BDNF) mRNA Isoforms in Brain Cells from Mecp2(308/y) Mouse Model.Visual evoked potentials detect cortical processing deficits in Rett syndrome.K+-Cl- co-transporter 2 (KCC2) - a membrane trafficking perspective.Environmental enrichment intervention for Rett syndrome: an individually randomised stepped wedge trial.Initial Observations of Salivary Brain-Derived Neurotrophic Factor Levels in Rett Syndrome.Diolistic Labeling and Analysis of Dendritic Spines.MeCP2 Modulates Sex Differences in the Postsynaptic Development of the Valproate Animal Model of Autism.TrkB blockade in the hippocampus after training or retrieval impairs memory: protection from consolidation impairment by histone deacetylase inhibition.Persistent Expression of Serotonin Receptor 5b Alters Breathing Behavior in Male MeCP2 Knockout Mice.Rett syndrome from bench to bedside: recent advances.Transcriptional Regulation by MECP2MECP2 regulates transcription of neuronal ligandsDual mechanisms for the regulation of brain-derived neurotrophic factor by valproic acid in neural progenitor cells
P2860
Q27023257-CF965344-F41B-45C4-B468-349BA7E2A9E0Q27025146-A170D7B4-D18D-4A83-8968-9494EF327C30Q27304440-B9AD71F6-E541-4214-8062-CBF0C0272570Q27337778-6DD5EEB5-21C7-475A-ABD0-636B6C3C18AAQ30357548-BAA43399-6710-41D3-AF28-53A010B1FED4Q30370242-D1792F44-81E5-4DBA-B442-1388066EC712Q30411312-CEDFDC5F-9FAE-46C6-9558-7455C03AE09BQ30431760-FA3A1F92-010A-46D5-9DFD-E22B8AF1AD28Q34462508-6F26F604-EC41-4D24-98CF-71F8E319F8B7Q34989741-674EAA53-9632-4F62-A92C-6CBE02270669Q35009147-C505B630-2321-40A9-A7DA-435346CAE13FQ35187479-89B978BC-41D7-4781-80A8-D03EF199915BQ35691182-FBA24D26-0EC4-456C-96B1-266734160075Q36064254-76703182-20CC-4386-88D3-AD5C465A7CB4Q36549401-B0E27F5E-D7ED-4210-9047-6272B855E2BCQ37292336-04221CDD-05DC-43FD-8EE1-B4DFED95BCC7Q37558440-048267A8-3C56-4C39-B84E-0BCCB2FB0DAFQ37676248-DB9A7A84-7DE7-49CD-9608-735C8E2FF79FQ37685373-54B1436F-B668-4B33-BCD3-C730ED668AD4Q37699493-A665D1AA-52E9-46D3-B87E-27FED79ED243Q38235909-5659E953-79B1-474B-B78C-D1674BB1CCCBQ38307079-9BCC023A-AC6E-44AE-8FF9-D83255838997Q38775542-5FDD240C-F71F-4ABB-AB9D-CB8DBD4C9C20Q38873613-DA74532D-4554-4F7D-A3A2-6D64AD8BC531Q39951877-24170702-24B0-4EF2-9211-61A2EC49B047Q40999723-F0F9ABCF-9D8D-488A-87B1-AFDCFFE7C3DCQ41433830-98BBDC5E-C174-4BAD-9B8A-7F7B17E696B9Q41507490-10BD2872-89E4-40EA-B177-6D6EB44708EEQ46675690-0FFE6317-D35B-42C1-ACF3-ACF119A3D7DDQ47343453-B679A4F3-A45C-4E3D-B472-7FD92FE4C88FQ47561755-7A73A036-0AAD-41B0-BBEF-05C3BE98FD4CQ47838107-D873C178-2212-451E-ABA5-DB94F73C832FQ47925108-DB737B94-9F06-4247-B5D4-ED27E5375CAAQ50303105-B518E36A-2996-42CF-873F-A41681AA5F3FQ50555578-72570AC4-4E2D-4316-802B-AC537F7C594DQ52363906-45A9C6DD-0A74-4FE9-8F5C-62FD71096F0BQ55312256-84E0FD31-84C4-4719-BE61-86AB43FE3A38Q56860951-E88E3AFC-402F-4EFB-A98C-79055AAB5E61Q56860954-D6116FF7-F996-411E-BA4A-BA21F971DC70Q58565218-B461A2F4-41E6-43AC-9714-EBDA2509BC44
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
BDNF deregulation in Rett syndrome
@ast
BDNF deregulation in Rett syndrome
@en
BDNF deregulation in Rett syndrome
@nl
type
label
BDNF deregulation in Rett syndrome
@ast
BDNF deregulation in Rett syndrome
@en
BDNF deregulation in Rett syndrome
@nl
prefLabel
BDNF deregulation in Rett syndrome
@ast
BDNF deregulation in Rett syndrome
@en
BDNF deregulation in Rett syndrome
@nl
P2860
P3181
P1433
P1476
BDNF deregulation in Rett syndrome
@en
P2093
P2860
P304
P3181
P356
10.1016/J.NEUROPHARM.2013.03.024
P407
P478
P577
2013-04-15T00:00:00Z